Nikhil Lalwani | executive |
Christopher Mutz | executive |
Stephen Carey | executive |
Jeremy Jacoby | analyst |
Gary Nachman | analyst |
Vamil Divan | analyst |
Oren Livnat | analyst |
Timothy Chiang | analyst |
Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc.
Second Quarter 2024 Earnings Results Call. Please note this call is being recorded. [Operator Instructions] It is now my pleasure to turn the conference over to Lisa Wilson. Please go ahead, ma'am.